Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current concepts in SARS treatment.

Takeshi Fujii1, Tetsuya Nakamura, Aikichi Iwamoto

  • 1Division of Infectious Diseases, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Japan. tmks@ims.u-tokyo.ac.jp

Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy
|March 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiretroviral therapies and status of people living with HIV in Japan: An update from hospital survey and national database.

PloS one·2025
Same author

Molecular Basis for the Recognition of HIV Nef138-8 Epitope by a Pair of Human Public T Cell Receptors.

Journal of immunology (Baltimore, Md. : 1950)·2022
Same author

Research impact analysis of international funding agencies in the realm of allergy and immunology.

Allergy·2022
Same author

Manganese toxicity disrupts indole acetic acid homeostasis and suppresses the CO<sub>2</sub> assimilation reaction in rice leaves.

Scientific reports·2021
Same author

Can Postoperative Distal Adding-On be Predicted in Lenke Type 1B and 1C Curves with Intraoperative Radiographs?

Spine·2021
Same author

Regulation of Immune Functions by Non-Neuronal Acetylcholine (ACh) via Muscarinic and Nicotinic ACh Receptors.

International journal of molecular sciences·2021
Same journal

Associations between delays in appropriate antimicrobial therapy or adequate source control and mortality adults with community-onset bacteremia: etiologic anaerobes vs. aerobes.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same journal

Legionnaire's disease with limbic encephalitis.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same journal

Early-onset pyomyoma mimicking post-embolization syndrome after uterine artery embolization: a case report and review of the literature.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same journal

Quantitative evaluation of pyuria with a hemocytometer in children on clean intermittent catheterization.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same journal

Device-Associated Infection Surveillance in Japan: 2025 Annual Report of the Japanese Society for Infection Prevention and Control.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same journal

Letter to the editor: Sex-stratified urinalysis thresholds and pre-analytic comparability in urine culture prediction.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
See all related articles

Severe acute respiratory syndrome (SARS) treatments remain unclear. Steroids may help SARS patients, but ribavirin showed no benefit and caused toxicity. Further research is needed.

Area of Science:

  • Infectious Diseases
  • Respiratory Medicine
  • Clinical Pharmacology

Background:

  • The 2003 severe acute respiratory syndrome (SARS) outbreak caused global fear, necessitating effective treatment strategies.
  • Despite numerous clinical reports, a consensus on SARS treatment remains elusive, with many approaches being anecdotal.
  • The potential for SARS recurrence underscores the need for evidence-based therapeutic guidelines.

Purpose of the Study:

  • To evaluate the effectiveness of various treatment regimens for severe acute respiratory syndrome (SARS).
  • To synthesize findings from 14 clinical reports to inform SARS therapeutic approaches.
  • To identify potential benefits and drawbacks of commonly used SARS treatments.

Main Methods:

  • Systematic review and assessment of 14 published clinical reports on SARS treatment.

Related Experiment Videos

  • Analysis of treatment regimens, including steroids, ribavirin, and interferon.
  • Evaluation of clinical outcomes such as intubation rates, mortality, and adverse events.

    • Main Results:

    • Corticosteroid therapy appeared beneficial for SARS patients, though optimal parameters (timing, dose, duration) require further definition.
    • Ribavirin treatment did not reduce the need for intratracheal intubation or mortality rates in SARS patients.
    • Ribavirin was associated with significant toxicity, notably hemolytic anemia, questioning its therapeutic utility.

    Conclusions:

    • Steroids show promise for SARS treatment, but require further investigation to optimize their use.
    • Ribavirin is not recommended for SARS due to lack of efficacy and significant adverse effects.
    • Interferon and other agents like glycyrrhizin and convalescent plasma warrant further evaluation for potential SARS treatment.